Srs Capital Advisors, Inc. Blueprint Medicines Corp Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 50 shares of BPMC stock, worth $4,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 57
12.28%
Holding current value
$4,521
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$601 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$514 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$387 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$226 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.4B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...